You need to enable JavaScript to run this app.
The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated
Cookie Policy
Yes, I accept cookies
Steering Committee
About Us
Newsletter
Contact
Visit:
Steering Committee
About Us
Newsletter
Contact
Types
Therapeutics
Congresses
Trials
Expert Opinions
ASH 2020
GvHD Types
Chronic graft-versus-host disease
Acute graft-versus-host disease
Graft-versus-host disease
View all Types
Florent Malard
Steering Committee Member
Florent Malard
Steering Committee Member
Types
Acute graft-versus-host disease
Chronic graft-versus-host disease
GI aGvHD
Steroid-refractory GvHD
Interventions
Alemtuzumab
Allo-HSCT
Antithymocyte globulin
Basiliximab
Begelomab
Bortezomib
Cyclophosphamide
Cyclosporin A
Etanercept
Extracorporeal photopheresis
Fecal microbiota transplant
Ibrutinib
Ixazomib
KD025
MaaT013
Mesenchymal stromal cells
Methotrexate
Microbiota therapy
Mycophenolate mofetil
Ruxolitinib
Sirolimus
Tacrolimus
α1-Antitrypsin
Congresses
ASH 2017
ASH 2018
ASH 2019
ASH 2020
EBMT 2020
EBMT GvHD Summit 2019
EHA 2019
IACH 2018
Trials
BMT CTN 1501
All
|
5 Articles
|
7 Videos
|
0 Podcasts